Blog
Category: Commercial Scale

Preparing for Cell and Gene Therapy 3.0

Blog

Patient data is mission-critical data — especially in cell and gene therapy.

In cell and gene therapy (CGT), the patient is the process is the…

Patient data – the unique role in cell and gene therapies (CGTs)

Blog

Patient data is mission-critical data — especially in cell and gene therapy.

In cell and gene therapy (CGT), the patient is the process is the…

Patient data – why it is critical for cell and gene therapy stakeholders

Blog

The first blog post in this series provided an overview of how the advanced therapies supply chain is different from traditional and biologic drug products…

Patient data – unique challenges, critical uses in the cell therapy value chain

Blog

The previous two blog posts in this series provided an overview of why patient-related data matters in cell therapy and gene therapy (CGTs), and how…

Integrated patient data – the future of advanced therapies

Blog

The cell and gene therapy (CGT) sector is poised for exponential growth — which will come in novel ways that reflect the unique nature of…

Life Sciences cybersecurity, knowing your first line of defense and continuously improving it

Blog

Pharmaceutical and biotech companies suffer more security breaches than any other industry1 — with greater than 20% of companies in the pharmaceutical sector having been…

Key industry and government regulations provide a cybersecurity foundation in advanced therapies

Blog

Pharmaceutical and biotech companies suffer more security breaches than any other industry1 — with greater than 20% of companies in the pharmaceutical sector having been…

Cybersecurity success in advanced therapies starts by prioritizing security as a “Way of working”

Blog

Pharmaceutical and biotech companies suffer more security breaches than any other industry1 — with greater than 20% of companies in the pharmaceutical sector having been…

Cybersecurity challenges in advanced therapies — introducing five strategies for success

Blog

Pharmaceutical and biotech companies suffer more security breaches than any other industry1 — with greater than 20% of companies in the pharmaceutical sector having been…

Biopharmaceutical and technology leaders form collaboration to promote standards and a modern patient ID for advanced therapies

Blog

Genentech, Takeda, Adaptimmune and other industry leaders join Vineti to form the core of this strategic collaboration. The group is...

Repost: a modern patient ID for personalized medicine

Blog

Today, Vineti released an announcement about new industry collaboration around our proposal for a new patient ID for cell and gene therapies....

Introducing new Vineti PTM® flexibility features: next-gen label printing and rescheduling innovations deliver critical workflow options that advanced therapies require

Blog

Introducing new Vineti PTM® flexibility features: next-gen label printing and rescheduling innovations deliver critical workflow options that advanced therapies require...